ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

Concepts Approved for Primary Care, Worker Health, Black Interventions

May 17, 1985

Hybridoma Cell Lines Available from NCI

September 3, 1982

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986

Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy

September 27, 2013